qyv26vz | Knowledge4COVID-19

Property	Value
?:creator	<https://research.tib.eu/covid-19/entity/Jim%C3%A9nez-Br%C3%ADtez%2C_Gustavo%3B_Ruiz%2C_Pablo%3B_Soler%2C_Xavier>
?:doi	10.1016/j.medcle.2020.07.009
?:doi	<https://research.tib.eu/covid-19/entity/10.1016/j.medcle.2020.07.009>
?:externalLink	<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836292/>
?:journal	Med_Clin_(Engl_Ed)
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/6435db112dec53f9e3ed20214eb5013b60f4be46.json
?:pmc_json_files	document_parses/pmc_json/PMC7836292.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7836292>
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/6435db112dec53f9e3ed20214eb5013b60f4be46>
?:source	PMC
?:title	Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-13

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/4qyv26vz>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/4qyv26vz>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all